Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.3 instead of v3.6.2, signaling a new site release. There are no changes to the study records or page navigation reflected by this update.
    Difference
    0.0%
    Check dated 2026-07-06T15:50:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The revision badge on the page updated from v3.6.0 to v3.6.2, signaling a platform release. No study data or navigation elements appear to be changed.
    Difference
    0.0%
    Check dated 2026-06-29T08:54:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The recruitment status changed to not actively recruiting participants, and the record history shows a new software revision (v3.6.0) with the prior revision (v3.5.5) removed.
    Difference
    0.2%
    Check dated 2026-06-15T05:35:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.5 as the latest entry, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T03:48:30.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor platform update to the page.
    Difference
    0.0%
    Check dated 2026-05-17T08:41:10.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page’s displayed interface/version label has been updated from “v3.5.0” to “v3.5.3,” indicating a site revision rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:02.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.